Why AI-Designed Drugs Entering Human Trials Signal the End of Traditional Pharmaceutical R&D Economics
Your pharma stocks just flatlined—AI designed molecules entering human trials prove that billion-dollar labs are solving yesterday’s…
Why DeepSeek R1’s 93.3% AIME Score Just Broke Enterprise AI Model Selection Forever
Your AI vendor just watched their pricing power evaporate while a Chinese startup rewrote the rules of model economics overnight.